The DOJ has accused CVS of enabling the opioid crisis through unsafe practices.
The United States government has accused CVS, one of the nation’s largest pharmacy chains, of playing a role in the ongoing opioid crisis by filling questionable prescriptions and billing federal programs for them. According to a government lawsuit recently unsealed in Rhode Island, CVS is alleged to have ignored red flags for over a decade, enabling dangerous drug combinations and excessive quantities of opioids to reach the public.
The Justice Department’s filing claims that the company’s policies encouraged pharmacists to prioritize speed and efficiency over safety, creating an environment where critical checks were overlooked. CVS reportedly continued filling prescriptions from certain doctors even after internal warnings or investigations surfaced about their practices. For instance, the company allegedly filled hundreds of prescriptions from an Alabama doctor under scrutiny for potential misconduct, who was later arrested. In Pennsylvania, CVS filled thousands of prescriptions from a physician flagged as questionable, including online reviews accusing him of indiscriminately prescribing medication without proper patient consultations.
The issue extends beyond individual cases. The lawsuit asserts that CVS’s corporate goals, which heavily emphasized performance metrics, led to unsafe practices. Whistleblower complaints highlighted this system, describing how pharmacists felt pressured to fulfill orders quickly, likening the process to an “assembly line” that prioritized profits. Employees warned management about the potential risks, but these warnings were allegedly ignored. The government’s complaint also mentions patients who lost their lives after obtaining drugs from CVS under questionable circumstances.
CVS has denied the government opioid allegations, claiming it cooperated with the investigation but disagrees with the accusations made by the Department of Justice. Previously, the company had agreed to a $5 billion settlement spread over ten years to resolve thousands of similar lawsuits brought by state and local governments as well as Native American tribes. Though CVS did not admit wrongdoing in that settlement, the Justice Department’s case focuses on specific examples where the company’s policies may have directly contributed to harmful outcomes.
The opioid crisis has claimed over 800,000 lives in the United States since 1999, according to data from the Centers for Disease Control and Prevention (CDC). While recent years have shown some progress in reducing overdose rates, the epidemic’s toll continues to weigh heavily on communities nationwide. Pharmacies like CVS, alongside manufacturers and distributors, have been targeted in numerous lawsuits as part of efforts to address the crisis. Critics argue that pharmacies should have acted as gatekeepers by flagging and refusing suspicious prescriptions rather than becoming complicit.
The Justice Department’s latest move stems from a whistleblower’s report. The former CVS employee alleged that inadequate staffing and relentless pressure to meet corporate targets led to a disregard for safety protocols. Employees voiced concerns internally, with one stating that the focus on speed over safety was bound to create problems when dealing with controlled substances. Despite such warnings, the lawsuit claims CVS continued business as usual, even in cases where pharmacists identified clear issues with prescriptions.
This case raises broader questions about the balance between efficiency and responsibility in healthcare delivery. Pharmacies are at the front line of prescription drug distribution, making them a critical checkpoint for preventing misuse. Yet, as this lawsuit suggests, when corporate priorities clash with safety measures, the consequences can be catastrophic. As legal proceedings unfold, the public will likely hear more about how systemic practices within large organizations may contribute to widespread problems like the opioid epidemic. For CVS, the allegations challenge the company’s public image as a trusted healthcare provider, putting its practices under intense scrutiny once again.
Sources:
US accuses CVS of filling, billing government for illegal opioid prescription
Complaint: UNITED STATES OF AMERICA, ex rel. HILLARY ESTRIGHT
Justice Department sues CVS for allegedly filling unlawful opioid prescriptions
Join the conversation!